A COVID-19 field hospital in Santo Andre, Brazil. The pandemic has killed over 503,000 people in Brazil; just 11% of the population is fully vaccinated.
Mario Tama/Getty Images
The high costs of the world’s colossally unequal COVID-19 immunization rates.
Indian health workers doing health checks in Mumbai, June 17, 2020.
AP Photo/Rafiq Maqbool, File
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
Globally, billions of dollars in public funds have been committed for COVID-19 vaccine development. It’s crucial that the resulting vaccine be accessible to all.
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
Access to affordable medical treatment can save lives.
The global cancer burden especially in developing countries is exacerbated by the high cost of treatment.
Are research nonprofits holding up their end of the tax-exempt bargain?
Holding patents can be a lucrative and powerful position to be in. Here’s a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
A cancer patient from Inner Mongolia seeks treatment in Beijing.
Of women who die from cervical cancer, 87% live in poor countries.
Trade minister Andrew Robb attends negotiations for the Trans Pacific Partnership in Sydney last year.
Dan Himbrechts/AAP Image
Over the next few weeks, the trade minister will be under intense pressure to renege on the government’s commitment to reject anything in the Trans Pacific Partnership that could undermine the PBS.
The proposed Australian price for Sovaldi has not been disclosed, but in the United States a three-month course of treatment costs US$84,000.
It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…
The intellectual property changes proposed by the United States won’t benefit poor countries party to the agreement.
Virginia Guard Public Affairs/Flickr
In the next few days, 12 Pacific Rim countries will make critical decisions about what is potentially the most damaging trade agreement for public health ever signed. The Trans Pacific Partnership agreement…